Need to file an Actos lawsuit? Contact Williams Kherkher today at 800-641-9810.

Takeda looking to get TAK-875 to pass in order to replace Actos sales

Posted on February 27th, 2012 No Comments

Takeda Pharmaceutical Co. is currently looking to pass a new drug,  TAK-875 and it is in its third and final stage of testing at this time. Takeda is hoping that this new drug will replace the sales from Actos, the Type 2 diabetes medication.

In the study done on TAK-875, the drug worked to reduce the blood sugar level by nearly 48 percent when they used the prescription for 12 weeks. The Japan-based company is hoping that this new drug’s sales will replace those from Actos because it is going to lose its patent at the end of the year.

TAK-875 is designed to help treat those who suffer from Type 2 diabetes and nearly 90 percent of the 285 million people that have this condition can use TAK-875 to treat it. Researchers from the University of Michigan Medical School have stated that new treatment for Type 2 diabetes is needed because the number of cases are expected to rise.

Actos has recently been linked to the development of bladder cancer when used for over a year, if this has happened to you or  a loved one. Contact the Actos lawsuit lawyers of Williams Kherkher by calling 800-641-9810 today.

Tagged , | Leave a comment

Contact Williams Kherkher




By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.

home  |  about us  |  attorneys  |  actos  |  bladder cancer  |  faqs  |  articles  |  law resources  |  press release  |  contact us  |  blog  |  Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +